FDA Inspection 1078188 — Aino Co., Ltd. Of North China Pharma. Group
The FDA completed an inspection of Aino Co., Ltd. Of North China Pharma. Group on Jan 17, 2019 in Shijiazhuang, Hebei. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang, Hebei (China)